IL273868A - שימוש בתרכובת, חומר ביניים סינתטי, תכשיר רוקחות ושיטה טיפולית של אפנון עצבי - Google Patents
שימוש בתרכובת, חומר ביניים סינתטי, תכשיר רוקחות ושיטה טיפולית של אפנון עצביInfo
- Publication number
- IL273868A IL273868A IL273868A IL27386820A IL273868A IL 273868 A IL273868 A IL 273868A IL 273868 A IL273868 A IL 273868A IL 27386820 A IL27386820 A IL 27386820A IL 273868 A IL273868 A IL 273868A
- Authority
- IL
- Israel
- Prior art keywords
- neuromodulatory
- compound
- pharmaceutical composition
- therapeutic method
- synthetic intermediate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000003227 neuromodulating effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102016023848-0A BR102016023848A2 (pt) | 2016-10-13 | 2016-10-13 | Anticonvulsivante, uso e composição farmacêutica contendo o mesmo |
| BR102017010169-0A BR102017010169A2 (pt) | 2017-05-15 | 2017-05-15 | composto, intermediário de síntese, uso na preparação de anticonvulsivante, composição farmacêutica anticonvulsivante |
| PCT/BR2017/050314 WO2018068120A1 (pt) | 2016-10-13 | 2017-10-11 | Uso de composto, intermediário de síntese, composição farmacêutica e método terapêutico neuromodulador |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL273868A true IL273868A (he) | 2020-05-31 |
| IL273868B1 IL273868B1 (he) | 2024-03-01 |
| IL273868B2 IL273868B2 (he) | 2024-07-01 |
Family
ID=61905035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL273868A IL273868B2 (he) | 2016-10-13 | 2017-10-11 | שימוש בתרכובת, חומר ביניים סינתטי, תכשיר רוקחות ושיטה טיפולית של אפנון עצבי |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL273868B2 (he) |
| WO (1) | WO2018068120A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR102017010169A2 (pt) * | 2017-05-15 | 2019-02-26 | Remer Consultores Assessoria Empresarial Ltda. | composto, intermediário de síntese, uso na preparação de anticonvulsivante, composição farmacêutica anticonvulsivante |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4851546B2 (ja) * | 2006-03-10 | 2012-01-11 | ジェンリン ディスカバリー | 肥満治療に有用なカンナビノイド受容体アンタゴニスト／インバースアゴニスト |
| BRPI0902481B8 (pt) * | 2009-07-31 | 2021-05-25 | Soc Beneficente De Senhoras Hospital Sirio Libanes | composição farmacêutica compreendendo hemopressina e seu uso. |
| GB201113596D0 (en) * | 2011-08-08 | 2011-09-21 | Univ De Coimbra | Compounds, compositions and methods to promote oligodendrogenesis and remyelination |
| BR102012017421A2 (pt) * | 2012-07-13 | 2015-04-14 | Proteimax Biotecnolgia Ltda | Peptídeo, composicão farmacêutica, ligante de receptor cb, metodo para modular a funcao de receptor cb, uso, método para o tratamento de obesidade, e, método para promover a redução de peso estetica em um indivíduo |
-
2017
- 2017-10-11 WO PCT/BR2017/050314 patent/WO2018068120A1/pt active Application Filing
- 2017-10-11 IL IL273868A patent/IL273868B2/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL273868B1 (he) | 2024-03-01 |
| IL273868B2 (he) | 2024-07-01 |
| WO2018068120A1 (pt) | 2018-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258931A (he) | תרכובות רפואיות ושיטות | |
| HK1247614A1 (zh) | 治療化合物及其用途 | |
| HK1258062A1 (zh) | 給予惡拉戈利的方法 | |
| HK1259372A1 (zh) | 治療化合物、其組合物及使用方法 | |
| IL267622A (he) | שיטה לשינוי אפקטים תרפויטיים של תרופות | |
| HK1248697A1 (zh) | 治療化合物及其用途 | |
| ZA201802033B (en) | Heteroaryl compounds and their use as therapeutic drugs | |
| GB201601703D0 (en) | Therapeutic compounds | |
| IL270011B (he) | תרכובות רפואיות ושיטות | |
| ZA201802256B (en) | Compounds and therapeutic uses thereof | |
| IL272385A (he) | תרכובת תרופה ושיטות לזיכוי | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| HK1256362A1 (zh) | 共晶、其製造方法及含有共晶的藥物 | |
| EP3192875A4 (en) | Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases | |
| HK1258056A1 (zh) | 治療性化合物和其使用方法 | |
| GB201616839D0 (en) | Therapeutic compounds | |
| EP3626727A4 (en) | COMPOUND, INTERMEDIATE SYNTHESIS, USE, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC METHOD OF NEUROMODULATION | |
| GB201406172D0 (en) | Therapy and pharmaceutical composition | |
| HK1223630A1 (zh) | 抗- 療法的實施與用量 | |
| IL265269B (he) | תרכובות חדשות ושימושים רפואיים שלהן | |
| IL289544A (he) | שיטות למתן תרפיה אנטי–פיברוטית | |
| GB201617339D0 (en) | Therapeutic compounds | |
| IL273868A (he) | שימוש בתרכובת, חומר ביניים סינתטי, תכשיר רוקחות ושיטה טיפולית של אפנון עצבי | |
| HK1258765A1 (zh) | 治療性化合物、組合物和它們的使用方法 | |
| EP3338771A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF TRAMADOL-ETORICOXIB CHLORHYDRATE FOR THE TREATMENT OF PAIN |